(PharmaNewsWire.Com, April 20, 2017 ) As per the syndicated report published by Market Data Forecast Europe OTC Drugs Market which is estimated to be USD 26.35 billion in 2016 is poised to reach USD 36.64 million by 2021, at a CAGR of 6.83% from 2016 to 2021. It can be attributed to the factors such as ease of accessibility, low cost, customer empowering qualities, convenience of usage as well as the cultural shift of people towards self-reliance. However certain challenges issues related to drug substance abuse must be dealt with to attain the full potential.
Over the counter(OTC) drugs are not only safe but effective drugs used for general ailments, and can be found at the pharmacies or local stores, over the counter, without the need of any permission from a doctor. Acetaminophen, ibuprofen and aspirin are the most common products of the OTC drugs market.
Free sample of the report is available at http://www.marketdataforecast.com/market-reports/europe-over-the-counter-drugs-market-511/request-sample In Europe, the public has started showing active approach towards the various ailments and are sticking with the lower priced alternates due to the rise costs of health care sector. Thus it has been noticed that various companies have been showing interest in the market lately.
Europe OTC Drugs Market is segmented based on product type, formulation type and distribution channels as mentioned below for attaining a more granular perspective of the market. In the report, each sub segment is provided with Market Size Estimations and Y-o-Y Forecasts.
Based on Product Type: Analgesics Cough, Cold and Flu Products Vitamins and Minerals Dermatological Products Gastrointestinal Products Ophthalmic Products Sleep Aids Products Weight Loss/Diet Products Others Based on Formulation Type: Tablets Liquids Ointments Sprays Based on Distribution Channels: Pharmacies Supermarkets/Hypermarkets Convenience Stores Others (Online Drug Stores)
Europe is an amalgamation of major economies like Germany, Spain, Italy, U.K. and France among others to name a few. The report justifies this by offering country wise data for the EU5 countries while taking some other predominant economies into consideration as well (Poland, Ukraine, Bulgaria and Rest of Europe). As per the study Germany and France are expected to hold the major market share while Ukraine and Bulgaria are the fastest growing markets in this region.
GlaxoSmithKline, Johnson and Johnson, Novartis, Bayer, Pfizer, Sanofi and Takeda n are the major players operating in the Europe OTC Drugs Market. According to recent reports, Indian drug giant, Torrent Pharma has come to terms to acquire a clutch of generic brands from Novartis.
The OTC Drugs market study offers the following deliverables:
Regional and country-level analysis that provides an innate perspective of European region and the aforementioned countries Meticulously identifying the key areas of market growth by providing market size forecasts and y-o-y estimations at a Segment-level analysis Explanations of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of macro and micro environmental factors that affect the European market presented in the form of PESTLE and Porters Five Forces Analyses Company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview of the key market players operating in the region Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies Expertly devised Market Outlook - Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Pharmaceuticals Segment:
About Market Data Forecast: The publisher of this report Market Data Forecast is well known for the services they render in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering Europe among other regions of the global market as well, that too with competitive pricing options.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
